Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment leaf node


URI

https://openalex.org/T11752

Label

Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment

Description

This cluster of papers focuses on the chemotherapy-induced peripheral neuropathy (CIPN) experienced by cancer patients, particularly in the context of breast cancer treatment. It covers various aspects such as the neurotoxic effects of taxanes and oxaliplatin, neuroprotective strategies, and the impact of CIPN on the quality of life of patients. Additionally, it discusses the use of microtubule-targeting agents like Eribulin Mesylate in cancer treatment.

Implementation

@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://openalex.org/T11752> a skos:Concept ;
    rdfs:label "Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment"@en ;
    rdfs:isDefinedBy openalex: ;
    owl:sameAs <https://en.wikipedia.org/wiki/Chemotherapy-induced_peripheral_neuropathy>,
        <https://openalex.org/T11752> ;
    skos:broader oasubfields:2730 ;
    skos:definition "This cluster of papers focuses on the chemotherapy-induced peripheral neuropathy (CIPN) experienced by cancer patients, particularly in the context of breast cancer treatment. It covers various aspects such as the neurotoxic effects of taxanes and oxaliplatin, neuroprotective strategies, and the impact of CIPN on the quality of life of patients. Additionally, it discusses the use of microtubule-targeting agents like Eribulin Mesylate in cancer treatment."@en ;
    skos:inScheme openalex: ;
    skos:prefLabel "Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment"@en ;
    openalex:cited_by_count 1115075 ;
    openalex:works_count 121183 .